When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 9 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Pancreatic Ductal / mortality)
Species Resource Title
Human and Animal Cells PANC-1(RCB2095) Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
Human and Animal Cells PANC-1(RCB2095) Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) Clinical relevance of CD70 expression in resected pancreatic cancer: Prognostic value and therapeutic potential.
Human and Animal Cells PANC-1(RCB2095) , PK-1(RCB1972) , PK-59(RCB1901) , PK-45H(RCB1973) , PK-45P(RCB2141) , KLM-1(RCB2138) , NOR-P1(RCB2139) Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome.
Human and Animal Cells PANC-1(RCB2095) BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Human and Animal Cells PANC-1(RCB2095) CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Human and Animal Cells NOR-P1(RCB2139) KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Human and Animal Cells PANC-1(RCB2095) , PK-1(RCB1972) Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.
Human and Animal Cells T3M-4(RCB1021) Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.